RFL

Rafael Holdings

• Seeking Alpha·5d ago

  Zevra Therapeutics: Cash Plus A Drug Priced Below Its Rival's Deal

• NASDAQ·10/04 06:01

  Rafael’s Trappsol Cyclo Misses Primary Endpoint, Targets 2026 FDA Filing

• Seeking Alpha·10/01 11:29

  Rafael Holdings: A Coin Flip With A Second Binary Attached - Hold

• Simply Wall St·10/01 10:51

  We're Keeping An Eye On Rafael Holdings' (NYSE:RFL) Cash Burn Rate

• Benzinga·09/30 17:39

  Why Is Rafael Stock Falling Wednesday?

• Benzinga·09/30 17:06

  12 Health Care Stocks Moving In Wednesday's Intraday Session

• NASDAQ·09/30 15:59

  Wednesday Sector Laggards: Real Estate, Agriculture & Farm Products

• Dow Jones·09/30 14:07

  Rafael Stock Slides as Niemann-Pick Disease Drug Fails to Meet Statistical Significance in Trial

• Benzinga·09/30 13:42

  Nasdaq Gains Over 100 Points; Jabil Posts Upbeat Earnings

• NASDAQ·09/30 12:08

  Rafael's Trappsol Cyclo Shows Significant Benefit In NPC Prespecified Analysis

• Benzinga·09/30 12:05

  12 Health Care Stocks Moving In Wednesday's Pre-Market Session

• TipRanks·09/30 11:52

  Rafael Holdings Reports Positive Phase 3 Trappsol Cyclo Data

• NASDAQ·09/30 11:41

  Rafael Reports Phase 3 Trappsol Cyclo Data In NPC

• TipRanks·09/30 11:25

  Rafael announces efficacy, safety data from Phase 3 TransportNPC study

• Benzinga·09/30 11:07

  Rafael Holdings Announced Topline Efficacy And Safety Data From Its Cyclo Therapeutics Subsidiary’s Phase 3 TransportNPC Study Evaluating Trappsol Cyclo In 94 Patients Diagnosed With Niemann-Pick Disease Type C; Trappsol Cyclo Did Not Achieve Statistical Significance